<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="neoplasia"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3612916/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612916/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Neoplasia (New York, N.Y.)"><meta name="citation_title" content="Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men"><meta name="citation_authors" content="Zhuo Chen, Jielin Sun, Seong-Tae Kim, Jack Groskopf, Junjie Feng, William B Isaacs, Roger S Rittmaster, Lynn D Condreay, Siqun Lilly Zheng, Jianfeng Xu"><meta name="citation_date" content="April 2013"><meta name="citation_issue" content="4"><meta name="citation_volume" content="15"><meta name="citation_firstpage" content="448"><meta name="citation_doi" content="10.1593/neo.122144"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3612916/?report=abstract"><meta name="citation_pmid" content="23555189"><meta name="DC.Title" content="Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Neoplasia Press"><meta name="DC.Contributor" content="Zhuo Chen"><meta name="DC.Contributor" content="Jielin Sun"><meta name="DC.Contributor" content="Seong-Tae Kim"><meta name="DC.Contributor" content="Jack Groskopf"><meta name="DC.Contributor" content="Junjie Feng"><meta name="DC.Contributor" content="William B Isaacs"><meta name="DC.Contributor" content="Roger S Rittmaster"><meta name="DC.Contributor" content="Lynn D Condreay"><meta name="DC.Contributor" content="Siqun Lilly Zheng"><meta name="DC.Contributor" content="Jianfeng Xu"><meta name="DC.Date" content="2013 Apr"><meta name="DC.Identifier" content="10.1593/neo.122144"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men"><meta property="og:type" content="article"><meta property="og:description" content="Prostate cancer gene 3 (PCA3) is a non-coding gene specifically overexpressed in prostate cancer (PCa) that has great potential as a clinical biomarker for predicting prostate biopsy outcome. However, genetic determinants of PCA3 expression level remain ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612916/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-neoplasia.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3612916/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3612916/pdf/neo1504_0448.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8C66DDDD551C3100000000091305E8.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3612916%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="mesh">MeSH</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/367/">Neoplasia</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/221284/">v.15(4); 2013 Apr</a></li><li class="accid">PMC3612916</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-neoplasia.gif" alt="Logo of neoplasia" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,30,118,50" alt="Guide for Authors" title="Guide for Authors" href="http://www.elsevier.com/journals/Neoplasia/1476-5586/guide-for-authors" ref="reftype=publisher&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="118,30,165,50" alt="About this journal" title="About this journal" href="http://www.journals.elsevier.com/Neoplasia" ref="reftype=publisher&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="165,30,286,50" alt="Explore this journal" title="Explore this journal" href="http://www.sciencedirect.com/science/journal/14765586" ref="reftype=publisher&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="Neoplasia (New York, N.Y.)" title="Neoplasia (New York, N.Y.)" href="http://www.neoplasia.com" ref="reftype=publisher&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Neoplasia</a></span>. 2013 Apr; 15(4): 448–453. </span></div><div>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1593%2Fneo.122144" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1593/neo.122144</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3612916</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23555189">23555189</a></div></div></div></div><h1 class="content-title">Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men<sup><a href="#FN1" rid="FN1" class=" fn">1</a>,</sup><sup><a href="#FN2" rid="FN2" class=" fn">2</a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Chen%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649779815216" co-class="co-affbox">Zhuo Chen</a>,<sup>*</sup><sup>†,</sup><sup>3</sup> <a href="/pubmed/?term=Sun%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649780447776" co-class="co-affbox">Jielin Sun</a>,<sup>*</sup><sup>†,</sup><sup>3</sup> <a href="/pubmed/?term=Kim%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649775207904" co-class="co-affbox">Seong-Tae Kim</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Groskopf%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649777101232" co-class="co-affbox">Jack Groskopf</a>,<sup>‡</sup> <a href="/pubmed/?term=Feng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649779950144" co-class="co-affbox">Junjie Feng</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Isaacs%20WB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649769178816" co-class="co-affbox">William B Isaacs</a>,<sup>§</sup> <a href="/pubmed/?term=Rittmaster%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649769176832" co-class="co-affbox">Roger S Rittmaster</a>,<sup>¶</sup> <a href="/pubmed/?term=Condreay%20LD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649762475248" co-class="co-affbox">Lynn D Condreay</a>,<sup>#</sup> <a href="/pubmed/?term=Zheng%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649762473264" co-class="co-affbox">Siqun Lilly Zheng</a>,<sup>*</sup><sup>†</sup> and  <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189" class="affpopup" co-rid="_co_idm140649758996096" co-class="co-affbox">Jianfeng Xu</a><sup>*</sup><sup>†</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140649779815216"><h3 class="no_margin">Zhuo Chen</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Chen%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Zhuo Chen</a></div></div><div id="_co_idm140649780447776"><h3 class="no_margin">Jielin Sun</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Sun%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Jielin Sun</a></div></div><div id="_co_idm140649775207904"><h3 class="no_margin">Seong-Tae Kim</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Kim%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Seong-Tae Kim</a></div></div><div id="_co_idm140649777101232"><h3 class="no_margin">Jack Groskopf</h3><p><sup>‡</sup>Gen-Probe Incorporated, San Diego, CA</p><div>Find articles by <a href="/pubmed/?term=Groskopf%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Jack Groskopf</a></div></div><div id="_co_idm140649779950144"><h3 class="no_margin">Junjie Feng</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Feng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Junjie Feng</a></div></div><div id="_co_idm140649769178816"><h3 class="no_margin">William B Isaacs</h3><p><sup>§</sup>Johns Hopkins Medical Institutions, Baltimore, MD</p><div>Find articles by <a href="/pubmed/?term=Isaacs%20WB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">William B Isaacs</a></div></div><div id="_co_idm140649769176832"><h3 class="no_margin">Roger S Rittmaster</h3><p><sup>¶</sup>Oncology, GlaxoSmithKline, Research Triangle Park, NC</p><div>Find articles by <a href="/pubmed/?term=Rittmaster%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Roger S Rittmaster</a></div></div><div id="_co_idm140649762475248"><h3 class="no_margin">Lynn D Condreay</h3><p><sup>#</sup>Genetics Development, GlaxoSmithKline, Research Triangle Park, NC</p><div>Find articles by <a href="/pubmed/?term=Condreay%20LD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Lynn D Condreay</a></div></div><div id="_co_idm140649762473264"><h3 class="no_margin">Siqun Lilly Zheng</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Zheng%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Siqun Lilly Zheng</a></div></div><div id="_co_idm140649758996096"><h3 class="no_margin">Jianfeng Xu</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23555189">Jianfeng Xu</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140649781264368_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140649781264368_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140649781264368_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140649781264368_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</div><div class="fm-affl" id="A2" lang="en"><sup>†</sup>Departments of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</div><div class="fm-affl" id="A3" lang="en"><sup>‡</sup>Gen-Probe Incorporated, San Diego, CA</div><div class="fm-affl" id="A4" lang="en"><sup>§</sup>Johns Hopkins Medical Institutions, Baltimore, MD</div><div class="fm-affl" id="A5" lang="en"><sup>¶</sup>Oncology, GlaxoSmithKline, Research Triangle Park, NC</div><div class="fm-affl" id="A6" lang="en"><sup>#</sup>Genetics Development, GlaxoSmithKline, Research Triangle Park, NC</div><div id="idm140649779255776">Address all correspondence to: Dr Jianfeng Xu or Dr Siqun Lilly Zheng, Center for Cancer Genomics, Medical Center Blvd, Winston-Salem, NC 27157. E-mail: <a href="mailto:dev@null" data-email="ude.htlaehekaw@uxj" class="oemail">ude.htlaehekaw@uxj</a>, <a href="mailto:dev@null" data-email="ude.htlaehekaw@gnehzs" class="oemail">ude.htlaehekaw@gnehzs</a></div><div id="FN3"><sup>3</sup>These authors contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140649781264368_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Dec 19; Revised 2013 Feb 6; Accepted 2013 Feb 7.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140649781264368_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  © 2013 Neoplasia Press, Inc. All rights reserved</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3612916/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Figures and Tables</div><div><a href="/pmc/articles/PMC3612916/bin/neo1504_0448SD1.pdf" data-ga-action="click_feat_suppl">neo1504_0448SD1.pdf</a><span style="color:gray"> (120K)</span></div><div class="small guid">GUID:&nbsp;17B741C4-064E-47AC-9387-387DAEFFF627</div></div></dd></dl></div><div id="idm140649776395040" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140649776395040title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last"><em>Prostate cancer gene 3</em> (<em>PCA3</em>) is a non-coding gene specifically overexpressed in prostate cancer (PCa) that has great potential as a clinical biomarker for predicting prostate biopsy outcome. However, genetic determinants of PCA3 expression level remain unknown. To investigate the association between genetic variants and PCA3 mRNA level, a genome-wide association study was conducted in 1371 men of European descent in the REduction by DUtasteride of prostate Cancer Events trial. First-voided urine specimens containing prostate cells were obtained after digital rectal examination. The PROGENSA PCA3 assay was used to determine PCA3 score in the urinary samples. A linear regression model was used to detect the associations between (single nucleotide polymorphisms) SNPs and PCA3 score under an additive genetic model, adjusting for age and population stratification. Two SNPs, rs10993994 in <em>β-microseminoprotein</em> at 10q11.23 and rs10424878 in <em>kallikrein-related peptidase 2</em> at 19q13.33, were associated with PCA3 score at genome-wide significance level (<em>P</em> = 1.22 x 10<sup>-9</sup> and 1.06 x 10<sup>-8</sup>, respectively). Men carrying the rs10993994 “T” allele or rs10424878 “A” allele had higher PCA3 score compared with men carrying rs10993994 “C” allele or rs10424878 “G” allele (<em>β</em> = 1.25 and 1.24, respectively). This is the first comprehensive search for genetic determinants of PCA3 score. The novel loci identified may provide insight into the molecular mechanisms of PCA3 expression as a potential marker of PCa.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p3" class="p p-first">Prostate cancer (PCa) is the most prevalent noncutaneous malignancy and the second leading cause of cancer mortality in the United States [<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629961">1</a>]. Prostate-specific antigen (PSA) is the most commonly used screening tool for PCa. PSA screening has led to progress in early detection [<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629984">2</a>]. However, elevated serum PSA is regularly detected in benign prostate disorders such as prostatitis and benign prostatic hyperplasia (BPH), resulting in a relatively high rate of unnecessary PSA-triggered biopsies [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629971">3</a>].</p><p id="__p4">Compared to PSA, <em>prostate cancer gene 3</em> (<em>PCA3</em>) is more specific for PCa. PCA3 is a prostate-specific non-coding mRNA that is over-expressed in prostate tumor tissue and metastases and is not observed in conjunction with benign prostate disorders such as prostatitis or enlarged prostate [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629972">4</a>]. Using PCA3, prostate tissue specimens containing less than 10% of cancer cells can be accurately discriminated from noncancer tissue [<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629985">4</a>]. PCA3 score is generated from the ratio of PCA3 mRNA level to PSA mRNA level, through which <em>PCA3</em> expression is normalized with the PSA expression used as a housekeeping gene. Recently, several independent studies have shown that PCA3 score has better performance than PSA in predicting prostate biopsy outcome in subjects with elevated PSA (&gt;2.5 ng/ml) [<a href="#R5" rid="R5 R6 R7 R8" class=" bibr popnode">5–8</a>]. PCA3 score was also observed to be indicative of biopsy Gleason score in the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_336920422">9</a>] and another study in a multidescent population by Nakanishi et al. [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629964">10</a>]. Moreover, PCA3 was correlated with prostate tumor size [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629979">10</a>].</p><p id="__p5" class="p p-last">Despite the well-characterized clinical use of PCA3, our knowledge of the genetic determinants of PCA3 expression levels is negligible. In this study, we conducted a genome-wide association study (GWAS) to identify SNPs that are associated with the urine level of PCA3 in the REDUCE trial.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Materials and Methods</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">Study Population</h3><p id="__p6" class="p p-first">Subjects in our GWAS were originally enrolled in the REDUCE trial, a 4-year multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the effect of dutasteride on the risk of PCa in men. Individuals participating in this trial had to meet the following criteria: 1) age between 50 and 75 years; 2) prostate volume (PV) ≤80 cm<sup>3</sup>; 3) PSA level of 2.5 to 10 ng/ml for subjects &lt;60 years old and 3 to 10 ng/ml for those ≥60 years; 4) negative biopsy (within 6 months of enrollment) for PCa, high-grade prostatic intraepithelial neoplasia, or atypical small acinar proliferation [<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629960">11</a>].</p><p id="__p7" class="p p-last">In the REDUCE trial, a total of 1649 individuals of European descent (885 in the placebo and 764 in the dutasteride treatment arms) had available PCA3 measurement. Among them, 162 of 885 subjects (18.3%) in the placebo and 116 of the 764 subjects (15.2%) in the dutasteride arm were diagnosed with PCa in the 4-year follow-up. The remaining 1371 individuals (723 in the placebo arm and 648 in the dutasteride arm) with negative prostate biopsy were included for further GWAS analysis. Characteristics of the 1371 individuals are summarized in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W1</a>.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Measurement of PCA3 and PSA mRNA Levels</h3><p id="__p8" class="p p-first-last">First-voided urine specimens containing prostate cells were obtained after digital rectal examination before year 2 and 4 biopsies. The PROGENSA PCA3 Assay was used to measure PCA3 and PSA mRNA levels in the urinary samples at an independent laboratory (Caris Life Sciences/Molecular Profiling Institute, Phoenix, AZ) [<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629980">12</a>].The firstavailable PCA3 and PSA value (at year 2 or year 4) was used in our analysis.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Genotyping, Imputation, and Quality Control</h3><p id="__p9" class="p p-first-last">Genotyping was conducted using an Illumina HumanOmniExpress BeadChip system (729,755; single nucleotide polymorphisms [SNPs] included) at the Center for Cancer Genomics, Wake Forest University School of Medicine. Samples with a genome-wide call rate ≥95% were included in subsequent GWAS analysis. For SNPs, the quality control criteria were as follows: minor allele frequency &gt;0.01, genotype call rate &gt;95%, and Hardy-Weinberg Equilibrium &gt;0.001. The remaining 586,462 SNPs were used to impute the genotypes of SNPs that were not directly genotyped in the genome, by IMPUTE software [<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629974">13</a>] using combined data of the 1000 Genomes low-coverage pilot project and HapMap3 data as references (<a href="http://www.1000genomes.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.1000genomes.org</a> and <a href="http://www.hapmap.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.hapmap.org</a>). The same quality control and a posterior probability of &gt;90% was applied to imputed SNP calls.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">Personalized PCA3 Score and Cutoffs</h3><p id="__p10" class="p p-first-last">Personalized PCA3 score and cutoff were calculated for each individual. First, a linear regression model was fitted, where log-transformed PCA3 scores were treated as outcomes and the number of alleles associated with higher PCA3 scores was treated as covariates. Genetic effects were calculated for three genotypes (aa, Aa, and AA), using the fitted values. Relative allelic effects (percentage of increase per allele) were calculated by dividing the fitted values of aa and Aa. The relative risk to the population for each genotype was then computed on the basis of the relative allelic effect and genotypic frequency. Second, assuming a multiplicative model, the combined relative genetic effect was calculated by multiplying the relative genotypic effect for each SNP relative to the general population. Third, a personalized PCA3 score for each subject was determined by dividing the raw PCA3 score by the combined relative genetic effect, while the personalized cutoff for each subject was generated by multiplying a uniform cutoff of 35 by the combined relative genetic effect.</p></div><div id="__sec7" class="sec sec-last"><h3 id="__sec7title">Statistical Analysis</h3><p id="__p11" class="p p-first">We calculated PCA3 score as follows: PCA3 mRNA copy number/PSA mRNA copy number x 1000. PSA mRNA copy number here was used to correct for the number of prostate cells present in urine sample. PCA3 score was log transformed to approximate a normal distribution for further analysis (<a href="#SD1" rid="SD1" class=" supplementary-material">Figure W1</a>).</p><p id="__p12" class="p p-last">A linear model implemented in PLINK software package [<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629969">14</a>] was used to detect the association of each SNP (genotyped and imputed) with PCA3 score under an additive genetic model in 1371 subjects negative for PCa biopsy. Principal component analysis was conducted to detect potential population stratification by EIGENSTRAT software [<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629981">15</a>]. Age and the top eigenvector that indicates ancestral heterogeneity within a group of individuals were adjusted as covariates in multiple regression analysis. Genome-wide significance level was set at a <em>P</em> value of 1 x 10<sup>-8</sup>. For regions containing more than one significant variant (<em>P</em> &lt;10<sup>-6</sup>), multiple linear regression analysis was applied to test the independence of each SNP, adjusting for the most significant SNPs, as well as all other covariates.</p></div></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Results</h2><p id="__p13" class="p p-first">Urine mRNA levels of PCA3, PSA (copies per milliliter, expressed as PCA3CPM and PSACPM, respectively), as well as the resulting PCA3 scores are summarized in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W1</a>. Although the median values of PCA3CPM and PSACPM in the dutasteride arm differed from those in the placebo arm (<em>P</em> &lt; .0001), PCA3 scores were not significantly different between dutasteride and placebo arms (Wilcoxon rank sum test, <em>P</em> = .72).</p><p id="__p14">In the present GWAS, a total of 3,076,666 SNPs (genotyped and imputed) were analyzed for association with log-transformed PCA3 score in 1371 subjects (placebo and dutasteride arms; <a href="/pmc/articles/PMC3612916/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). The inflation factor of GWAS results based on a quantile-quantile (Q-Q) plot analysis was modest (λ = 1.01; <a href="#SD1" rid="SD1" class=" supplementary-material">Figure W2</a>). Therefore, the reported <em>P</em> values are not corrected for genomic inflation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3612916/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140649781228864" class="figure"><a href="/pmc/articles/PMC3612916/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3612916_neo1504_0448_fig001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is neo1504_0448_fig001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3612916/bin/neo1504_0448_fig001.jpg"></a></div><div id="largeobj_idm140649781228864" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3612916/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3612916/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p44">Manhattan plot of genome-wide association analyses for PCA3 score in 1371 subjects with negative prostate biopsy. The <em>x</em>-axis represents chromosomal position; the <em>y</em>-axis represents -log<sub>10</sub>
<em>P</em> values from linear regression. The red horizontal solid line indicates the preset threshold of <em>P</em> = 1 x 10<sup>-8</sup>.</p></div></div></div><p id="__p15">Two SNPs, rs10993994 in the <em>β-microseminoprotein</em> (<em>MSMB</em>) gene at 10q11.23 and rs10424878 in the <em>kallikrein-related peptidase 2</em> (<em>KLK2</em>) gene at 19q13.33, reached a genome-wide significant <em>P</em> value of 1.22 x 10<sup>-9</sup> and 1.06 x 10<sup>-8</sup>, respectively (<a href="/pmc/articles/PMC3612916/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), adjusting for age and the top eigenvector for potential population stratification in an additive model. Seventeen SNPs with a <em>P</em> value smaller than 1 x 10<sup>-6</sup> are presented in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W2</a>. Several other SNPs in the <em>MSMB</em> gene region or <em>KLK2/kallikrein-related peptidase 3</em> (<em>KLK3</em>) gene cluster were significant in the <em>P</em> value range of 1 x 10<sup>-6</sup> to 1 x 10<sup>-8</sup> (<a href="/pmc/articles/PMC3612916/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>, <em>A</em> and <em>B</em>). After adjusting for the most significant SNPs and all other covariates, none of the other SNPs in the <em>MSMB</em> or <em>KLK2/KLK3</em> regions remained independently associated with PCA3 score. No significant association between PCa risk and the 183 SNPs within or surrounding the <em>PCA3</em> gene at 9q21 (78,519,174–78,642,285, NCBI build 36) was detected.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3612916/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140649759458064" class="figure"><a href="/pmc/articles/PMC3612916/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3612916_neo1504_0448_fig002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is neo1504_0448_fig002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3612916/bin/neo1504_0448_fig002.jpg"></a></div><div id="largeobj_idm140649759458064" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3612916/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3612916/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p45">Association of PCA3 score at 10q11.23 (A) and 19q13.33 (B) in 1371 subjects with negative prostate biopsy. The <em>x</em>-axis represents chromosomal position; the <em>y</em>-axis represents -log<sub>10</sub>
<em>P</em> values from linear regression. Solid purple lines represent recombination rate in cM/MB. Each plotted point represents one SNP.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p46">SNPs Associated with PCA3 Score in 1371 Subjects with Negative Prostate Biopsy.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140649759455488" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><td rowspan="1" colspan="1">SNP</td><td rowspan="1" colspan="1">Chr</td><td rowspan="1" colspan="1">BP<sup>*</sup></td><td rowspan="1" colspan="1">Gene</td><td rowspan="1" colspan="1">Alleles</td><td colspan="2" rowspan="1">Risk Allele</td><td colspan="3" rowspan="1">Mean of PCA3 Score<sup>†</sup></td><td rowspan="1" colspan="1"><em>β</em> (SE)<sup>‡</sup></td><td rowspan="1" colspan="1"><em>P</em><sup>‡</sup></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td colspan="2" rowspan="1"><hr></td><td colspan="3" rowspan="1"><hr></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Allele</td><td rowspan="1" colspan="1">Freq</td><td rowspan="1" colspan="1">LL</td><td rowspan="1" colspan="1">LH</td><td rowspan="1" colspan="1">HH</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">rs10993994</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">51,219,502</td><td rowspan="1" colspan="1"><em>MSMB</em></td><td rowspan="1" colspan="1">C/T</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">0.41</td><td rowspan="1" colspan="1">13.35</td><td rowspan="1" colspan="1">16.82</td><td rowspan="1" colspan="1">20.11</td><td rowspan="1" colspan="1">1.25 (0.037)</td><td rowspan="1" colspan="1">1.22 x 10<sup>-9</sup></td></tr><tr><td rowspan="1" colspan="1">rs10424878</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">56,066,779</td><td rowspan="1" colspan="1"><em>KLK2</em></td><td rowspan="1" colspan="1">G/A</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">0.40</td><td rowspan="1" colspan="1">13.68</td><td rowspan="1" colspan="1">16.61</td><td rowspan="1" colspan="1">20.76</td><td rowspan="1" colspan="1">1.24 (0.038)</td><td rowspan="1" colspan="1">1.06 x 10<sup>-8</sup></td></tr></tbody></table></div><div id="largeobj_idm140649759455488" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3612916/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF1"><sup>*</sup>BP genomic position is based on NCBI build 36.</div><div id="TF2"><sup>†</sup>The mean values of PCA3 score are back log-transformed. LL indicates homozygous carriers of the allele that is associated with a lower value of PCA3 score; LH indicates heterozygous carrier of the allele that is associated with a lower value of PCA3 score; HH indicates homozygous carriers of the allele that is associated with a higher value of PCA3 score.</div><div id="TF3"><sup>‡</sup>The <em>P</em> values are based on linear regression analysis on the log-transformed PCA3 score and adjusted for age and the top eigenvector assuming an additive model; <em>β</em> is back log-transformed, while SE is log-transformed.</div></div></div><p id="__p16">The effects of rs10993994 and rs10424878 on PCA3 score were then evaluated. As shown in <a href="/pmc/articles/PMC3612916/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>, the least square mean values of PCA3 score were 13.35, 16.82, and 20.11 for the rs10993994 CC, CT, and TT carriers, respectively (<em>β</em> = 1.25 for “T” allele). The least square mean values of PCA3 score were 13.68, 16.61, and 20.76 for rs10424878 GG, AG, and AA carriers, respectively (<em>β</em> = 1.24 for “A” allele).</p><p id="__p17">In addition, we examined the associations of the two top SNPs with PCa risk, baseline PV, and International Prostate Symptom Score (IPSS; <a href="#SD1" rid="SD1" class=" supplementary-material">Table W3</a>). The SNP rs10993994 was significantly associated with PCa risk (odds ratio [OR] = 1.20, <em>P</em> = .02), baseline PV (<em>β</em> = 0.03, <em>P</em> = .01), and IPSS (β = -0.27, <em>P</em> = .05). The SNP rs10424878 was not significantly associated with PCa risk (OR = 1.08, <em>P</em> = .35) or baseline IPSS (<em>β</em> = 0.04, <em>P</em> = .76) but was associated with baseline PV (<em>β</em> = -0.02, <em>P</em> = .02).</p><p id="__p18" class="p p-last">Moreover, a personalized cutoff value of PCA3 score was estimated for each individual. The estimated personalized cutoff ranged from 24.9 to 60.6. The estimated personalized cutoff was 24.9 for subjects carrying both the rs10993994 CC genotype and the rs10424878 GG genotype, while it was 60.6 for subjects carrying both the rs10993994 TT genotype and the rs10424878 AA genotype (<a href="#SD1" rid="SD1" class=" supplementary-material">Figure W3</a>).</p></div><div id="__sec9" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec9title">Discussion</h2><p id="__p19" class="p p-first">In the present GWAS, conducted among 1371 European descent men with negative prostate biopsies, the strongest overall effects on PCA3 score were observed for two independent genetic variants, rs10993994 in <em>MSMB</em> at 10q11.21 (<em>P</em> = 1.22 x 10<sup>-9</sup>) and rs10424878 in <em>KLK2</em> at 19q13.33 (<em>P</em> = 1.06 x 10<sup>-8</sup>). Presently, this is the first discovery of genetic determinants based on a genome-wide study for PCA3, one of the most valuable early detection biomarkers for PCa.</p><p id="__p20">SNP rs10993994 is located 57 bp upstream of exon 1 of the <em>MSMB</em> gene, which encodes MSMB, one of the major constituents of seminal plasma [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629967">16</a>]. MSMB is a member of immunoglobulin binding factor family and can act as a tumor suppressor by binding to cell surface receptors and regulating prostate cell apoptosis through mitogen-activated protein (MAP) kinase/AKT signaling [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629959">17</a>]. Previous studies discovered that the expression of <em>MSMB</em> is much higher in normal and benign prostate tissues than in tumor tissues [<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629983">18</a>] and urinary MSMB level decreases during tumorigenesis [<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629976">19</a>].</p><p id="__p21">As the most thoroughly studied genetic variant in the <em>MSMB</em> gene region, rs10993994 has been reported to be associated with PCa [<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629966">20</a>] and this association appears to be independent of age at diagnosis or tumor grade [<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629968">21</a>]. Functional investigation revealed that the minor allele “T” of rs10993994 was causally associated with lower expression of <em>MSMB</em>, because replacement of wild-type C to T altered a cAMP response element-binding protein transcription binding site, resulting in reduced promoter activity [<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629970">22</a>]. Fine mapping of the <em>MSMB</em> promoter region did not identify other SNPs having major effects regulating MSMB expression [<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629975">22</a>]. Taken together, these findings suggest rs10993994 as a potential independent causal genetic variant for PCa.</p><p id="__p22">In our study, rs10993994 in <em>MSMB</em> was associated with PCA3 score, a risk factor for PCa. The T allele, associated with a decrease in MSMB promoter activity and an increase in PCa risk, was associated with an increase in urinary PCA3. Since rs10993994 was associated with PCa risk in the placebo arm of REDUCE trial (OR = 1.20, <em>P</em> = .02), one potential scenario is, even in this population of men screened for PCa, men with the T allele would be more likely to have (undetected) PCa and thus have a higher urinary PCA3. However, if this was the explanation, one would expect other PCa risk SNPs (e.g., SNPs at 8q24 and <em>HNF1B</em>) to be associated with urinary PCA3. Except for rs10993994, the majority of the other 32 known PCa risk-associated SNPs [<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629958">23</a>] were not significantly associated with PCA3 score (<em>P</em> &gt; .0016, Bonferroni corrected for 32 tests), and only two of these documented PCa risk SNPs, rs10486567 and rs1512268, have <em>P</em> values slightly smaller than .0016 (.0005 and .0010, respectively). Therefore, it is unlikely that rs10993994 affects PCA3 score through this mechanism.</p><p id="__p23">Given that rs10993994 in MSMB is also associated with serum PSA levels, we also considered the possibility that rs10993994 affects PCA3 score indirectly through PSA. Additional association analysis of PCA3 score in which urinary PSA level was adjusted as a covariate showed that urinary PSA level had little effect on PCA3 score (<em>P</em> = .84). Moreover, rs10993994 is not statistically related to serum PSA level among the 1371 subjects in our study (<em>P</em> = .37, adjusted for age and the top eigenvector). Therefore, the association between rs10993994 and PCA3 score found in our study is most likely to be independent of PSA level in urine or in serum.</p><p id="__p24">Since rs10993994 is located within an androgen receptor binding region [<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629965">24</a>] and androgen signaling plays an important role in the pathogenesis of PCa [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629963">25</a>], it is possible that rs10993994 has an effect on PCA3 score through the androgen action pathway. In the present study, 648 of the total 1371 subjects were in the dutasteride arm. Dutasteride is a 5α-reductase inhibitor that reduces systemic and tissue levels of 5α-dihydrotestosterone, the principal androgen in the prostate [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629982">25</a>]. Therefore, we compared the effects of rs10993994 on PCA3 score in the placebo and dutasteride arms separately. The <em>β</em> values of the T allele in an additive model (adjusted for age and the top eigenvector) in 723 placebo subjects and 648 dutasteride subjects were 1.27 and 1.24, respectively, with <em>P</em> values of 2.5 x 10<sup>-6</sup> and 6.7 x 10<sup>-5</sup>. The effects of rs10993994 on PCA3 score were quite similar in the two arms. On the basis of these results, rs10993994 may not affect PCA3 score through the androgen pathway.</p><p id="__p25">There is still another scenario that may explain the association between rs10993994 and PCA3 score. There may be some currently unknown downstream relationship whereby the level of MSMB expression directly affects the production of PCA3 mRNA or its ability to get into the urine. However, <em>in vitro</em> studies with PCA3-producing cell lines and other functional studies are required to address this hypothesis.</p><p id="__p26">The second SNP associated with PCA3 score, rs10424878, is about 2kbupstream of <em>KLK2</em>, the coding gene of KLK2. As a member of kallikrein gene family, KLK2 is a serine protease and can activate urokinase-type plasminogen activator, cleave binding proteins of insulin-like growth factor, and cleave the preform of PSA to the mature enzyme, participating in a proteolytic cascade, which has been associated with tumorigenesis and metastasis of PCa [<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629962">26</a>]. In addition, PCa tumor tissues have a higher KLK2 expression level than benign tissues [<a href="#R27" rid="R27 R28" class=" bibr popnode">27,28</a>] and patients with PCa were also found to have higher serum KLK2 [<a href="#R29" rid="R29 R30" class=" bibr popnode">29,30</a>].</p><p id="__p27">Genetic variants in <em>KLK2</em> were found to be associated with PCa in candidate gene association studies [<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629977">31</a>], although no SNPs in <em>KLK2</em> have been confirmed or identified by GWAS. In our GWAS on PCA3 score, rs10424878 and another nine SNPs in <em>KLK2</em> and five SNPs in <em>KLK3</em> reached a <em>P</em> value of 1 x 10<sup>-6</sup>. However, the associations between all of the other 14 <em>KLK2/KLK3</em> SNPs and PCA3 score no longer existed after adjusting for rs10424878 (<em>P</em> &gt; .05), indicating that rs10424878 is the only independent SNP in <em>KLK</em>s that is associated with PCA3 score. Unfortunately, little is known about the pathways or functional relationships between the <em>KLK2</em> and <em>PCA3</em> gene. Additional association analysis of PCA3 score in which urinary PSA level was adjusted as a covariate showed that urinary PSA level had little effect on PCA3 score (<em>P</em> = .89). We also assessed serum PSA level with rs10424878, and no association was found (<em>P</em> = .12, adjusted for age and the top eigenvector). Overall, the effect of rs10424878 on PCA3 scores was unlikely to be mediated through serum PSA levels.</p><p id="__p28">Another possible impact of rs10424878/<em>KLK2</em> on PCA3 score could be through the androgen action pathway, since <em>KLK2</em> is highly responsive to androgens. As mentioned, androgen signaling is important for PCa pathogenesis [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629978">25</a>] and dutasteride could greatly reduce 5α-dihydrotestosterone levels [<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304629973">25</a>]. Similar to rs10993994, we assessed the effect of rs10424878 on PCA3 score separately in the placebo and dutasteride arms. The <em>β</em> values of “A” allele in an additive model (adjusted for age and the top eigenvector) in 723 placebo subjects only and 648 dutasteride subjects only are 1.22 and 1.26, respectively, with <em>P</em> values of 2.06 x 10<sup>-4</sup> and 1.13 x 10<sup>-5</sup>. The effects of rs10424878 on PCA3 score were quite similar in the two arms. Therefore, it is unlikely that rs10424878 affects PCA3 score through the androgen pathway. Additional biologic studies are needed to elucidate the mechanism through which rs10424878 impacts urine PCA3 scores.</p><p id="__p29">On the basis of genetic discovery, we estimated personalized PCA3 scores for 1649 subjects with PCA3 measurements, including 278 subjects with positive prostate biopsy results and 1371 with negative biopsy results. We compared the area under curve (AUC) between the model with the raw PCA3 score and the model with the personalized PCA3 score for predicting prostate biopsy outcome. The AUCs for both models were 0.681 and 0.682, respectively. We did not observe a statistically significant difference in AUCs between the two models, which may due to the limited number of genetic determinants identified for the PCA3 score and the relatively small effect of each variant. Although the personalized PCA3 scores showed limited improvement in AUC compared with the raw PCA3 scores, the detection rate of positive prostate biopsy was higher for men with 35 and higher for the personalized PCA3 score (31.0%, 120/388) compared with the detection rate for men with 35 and higher for the raw PCA3 score (28.3%, 119/421). Overall, improvement in clinical use of the personalized PCA3 score was limited in the current study. However, it may improve if more genetic variants for PCA3 score are identified in future studies.</p><p id="__p30">Two advantages of this study were its prospective design and the stringent inclusion and exclusion criteria. Nevertheless, several limitations need to be addressed. Although the most stringent Bonferroni correction was applied to control false positive findings, our study did not include a confirmation stage in an independent population, due to the difficulty in identifying additional studies with available germline DNA, PCA3 measurements, and prostate biopsy outcomes. Another limitation is that only two SNPs were identified to be associated with PCA3 score at a genome-wide level in this study. Therefore, further discoveries and validations across populations are warranted.</p><p id="__p31" class="p p-last">In conclusion, this study represents the first effort to investigate genetic determinants of PCA3 score, which may advance the understanding of PCA3 score. More importantly, the genetic determinants identified might be helpful to facilitate the utilization of personalized cutoff of PCA3 score as a marker for PCa prediction.</p></div><div id="__sec10" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec10title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><!--caption a9--><strong>Supplementary Figures and Tables:</strong><div class="sup-box half_rhythm" id="d35e728"><a href="/pmc/articles/PMC3612916/bin/neo1504_0448SD1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(120K, pdf)</sup></div></div></div><div id="idm140649779518208" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140649779518208title">Acknowledgments</h2><div class="sec"><p id="__p32">We thank the patients enrolled in REDUCE (sponsored by GSK) who provided consent and genetic samples that enabled this study, and the clinicians who contributed their expertise in recruiting study patients for the REDUCE clinical study. Dave Pulford, Jennifer Aponte, Jon Charnecki, and Mary Ellyn Volk participated in consent reconciliation and sample management to enable genetic sample selection for inclusion and genotype determination. Karen King provided data management support for this project. We appreciate the assistance of Lauren Marmor in coordinating the support of the Avodart Collaborative Research Team.</p></div></div><div id="idm140649778031904" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140649778031904title">Abbreviations</h2><div class="bk-sec"><div id="DL1"><table class="default-table glossary"><tbody><tr><td>GWAS</td><td>genome-wide association study</td></tr><tr><td>REDUCE</td><td>REduction by DUtasteride of prostate Cancer Events</td></tr><tr><td>PCa</td><td>prostate cancer</td></tr><tr><td>PSA</td><td>prostate-specific antigen</td></tr><tr><td><em>PCA3</em></td><td><em>prostate cancer gene 3</em></td></tr><tr><td>MSMB</td><td>β-microseminoprotein</td></tr><tr><td>KLK2</td><td>kallikrein-related peptidase 2</td></tr><tr><td>KLK3</td><td>kallikrein-related peptidase 3</td></tr><tr><td>IPSS</td><td>International Prostate Symptom Score</td></tr></tbody></table></div></div></div><div id="idm140649779516688" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140649779516688title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><sup>1</sup>This work was supported by a National Cancer Institute RC2 grant (CA148463) and a research contract by GlaxoSmithKline (GSK) to J.X. L.D.C. and R.S.R. were GSK employees during this study and hold stock in GSK. J.G. is an employee of Hologic Gen-Probe, which supported PROGENSA PCA3 Assay testing under contractual agreement with GSK. J.X. certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), have been disclosed.</p><p class="fn sec" id="FN2"><sup>2</sup>This article refers to supplementary materials, which are designated by <a href="#SD1" rid="SD1" class=" supplementary-material">Tables W1</a> to <a href="#SD1" rid="SD1" class=" supplementary-material">W3</a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Figures W1</a> to <a href="#SD1" rid="SD1" class=" supplementary-material">W3</a> and are available online at <a href="http://www.neoplasia.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.neoplasia.com</a>.</p></div></div><div id="idm140649777999136" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140649777999136title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. <span><span class="ref-journal">CA Cancer J Clin. </span>2009;<span class="ref-vol">59</span>:225–249.</span> [<a href="/pubmed/19474385" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;title=Cancer+statistics,+2009&amp;author=A+Jemal&amp;author=R+Siegel&amp;author=E+Ward&amp;author=Y+Hao&amp;author=J+Xu&amp;volume=59&amp;publication_year=2009&amp;pages=225-249&amp;pmid=19474385&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. <span><span class="ref-journal">J Natl Cancer Inst. </span>2009;<span class="ref-vol">101</span>:1325–1329.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2758309/">PMC free article</a>]</span> [<a href="/pubmed/19720969" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Prostate+cancer+diagnosis+and+treatment+after+the+introduction+of+prostate-specific+antigen+screening:+1986–2005&amp;author=HG+Welch&amp;author=PC+Albertsen&amp;volume=101&amp;publication_year=2009&amp;pages=1325-1329&amp;pmid=19720969&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Pannek J, Partin AW. Prostate-specific antigen: what's new in 1997. <span><span class="ref-journal">Oncology (Williston Park) </span>1997;<span class="ref-vol">11</span>:1273–1278.</span> discussion 1279–1282. [<a href="/pubmed/9306417" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncology+(Williston+Park)&amp;title=Prostate-specific+antigen:+what's+new+in+1997&amp;author=J+Pannek&amp;author=AW+Partin&amp;volume=11&amp;publication_year=1997&amp;pages=1273-1278&amp;pmid=9306417&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)based molecular urine analysis for the diagnosis of prostate cancer. <span><span class="ref-journal">Eur Urol. </span>2003;<span class="ref-vol">44</span>:8–15.</span> discussion 15–16. [<a href="/pubmed/12814669" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Urol&amp;title=DD3(PCA3)based+molecular+urine+analysis+for+the+diagnosis+of+prostate+cancer&amp;author=D+Hessels&amp;author=JM+Klein+Gunnewiek&amp;author=I+van+Oort&amp;author=HF+Karthaus&amp;author=GJ+van+Leenders&amp;volume=44&amp;publication_year=2003&amp;pages=8-15&amp;pmid=12814669&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Aubin SM, Reid J, Sarno MJ, Blase A, Aussie J, Rittenhouse H, Rittmaster R, Andriole GL, Groskopf J. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial. <span><span class="ref-journal">J Urol. </span>2010;<span class="ref-vol">184</span>:1947–1952.</span> [<a href="/pubmed/20850153" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=PCA3+molecular+urine+test+for+predicting+repeat+prostate+biopsy+outcome+in+populations+at+risk:+validation+in+the+placebo+arm+of+the+dutasteride+REDUCE+trial&amp;author=SM+Aubin&amp;author=J+Reid&amp;author=MJ+Sarno&amp;author=A+Blase&amp;author=J+Aussie&amp;volume=184&amp;publication_year=2010&amp;pages=1947-1952&amp;pmid=20850153&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Ochiai A, Okihara K, Kamoi K, Iwata T, Kawauchi A, Miki T, Fors Z. Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy. <span><span class="ref-journal">Int J Urol. </span>2011;<span class="ref-vol">18</span>:200–205.</span> [<a href="/pubmed/21332814" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Urol&amp;title=Prostate+cancer+gene+3+urine+assay+for+prostate+cancer+in+Japanese+men+undergoing+prostate+biopsy&amp;author=A+Ochiai&amp;author=K+Okihara&amp;author=K+Kamoi&amp;author=T+Iwata&amp;author=A+Kawauchi&amp;volume=18&amp;publication_year=2011&amp;pages=200-205&amp;pmid=21332814&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Roobol MJ, Schroder FH, van Leeuwen P, Wolters T, van den Bergh RC, van Leenders GJ, Hessels D. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. <span><span class="ref-journal">Eur Urol. </span>2010;<span class="ref-vol">58</span>:475–481.</span> [<a href="/pubmed/20637539" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Urol&amp;title=Performance+of+the+prostate+cancer+antigen+3+(PCA3)+gene+and+prostate-specific+antigen+in+prescreened+men:+exploring+the+value+of+PCA3+for+a+first-line+diagnostic+test&amp;author=MJ+Roobol&amp;author=FH+Schroder&amp;author=P+van+Leeuwen&amp;author=T+Wolters&amp;author=RC+van+den+Bergh&amp;volume=58&amp;publication_year=2010&amp;pages=475-481&amp;pmid=20637539&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL, Jr, et al.  Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. <span><span class="ref-journal">JUrol. </span>2012;<span class="ref-vol">188</span>:1726–1731.</span> [<a href="/pubmed/22998901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JUrol&amp;title=Diagnostic+performance+of+PCA3+to+detect+prostate+cancer+in+men+with+increased+prostate+specific+antigen:+a+prospective+study+of+1,962+cases&amp;author=ED+Crawford&amp;author=KO+Rove&amp;author=EJ+Trabulsi&amp;author=J+Qian&amp;author=KP+Drewnowska&amp;volume=188&amp;publication_year=2012&amp;pages=1726-1731&amp;pmid=22998901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Rittmaster R, Aubin SMJ, Reid J, Sarno MJ, Blase A, Aussie J, Rittenhouse H, Andriole GL, Groskopf J. Validation of the PCA3 molecular urine test for prediction repeat prostate biopsy outcome in the placebo arm of the dutasterided REDUCE trial. <span><span class="ref-journal">Eur Urol. </span>2010;<span class="ref-vol">184</span>:1947–1952.</span> [<a href="/pubmed/20850153" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Urol&amp;title=Validation+of+the+PCA3+molecular+urine+test+for+prediction+repeat+prostate+biopsy+outcome+in+the+placebo+arm+of+the+dutasterided+REDUCE+trial&amp;author=R+Rittmaster&amp;author=SMJ+Aubin&amp;author=J+Reid&amp;author=MJ+Sarno&amp;author=A+Blase&amp;volume=184&amp;publication_year=2010&amp;pages=1947-1952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. <span><span class="ref-journal">J Urol. </span>2008;<span class="ref-vol">179</span>:1804–1809.</span> discussion 1809-1810. [<a href="/pubmed/18353398" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=PCA3+molecular+urine+assay+correlates+with+prostate+cancer+tumor+volume:+implication+in+selecting+candidates+for+active+surveillance&amp;author=H+Nakanishi&amp;author=J+Groskopf&amp;author=HA+Fritsche&amp;author=V+Bhadkamkar&amp;author=A+Blase&amp;volume=179&amp;publication_year=2008&amp;pages=1804-1809&amp;pmid=18353398&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. <span><span class="ref-journal">J Urol. </span>2004;<span class="ref-vol">172</span>:1314–1317.</span> [<a href="/pubmed/15371831" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=Chemoprevention+of+prostate+cancer+in+men+at+high+risk:+rationale+and+design+of+the+reduction+by+dutasteride+of+prostate+cancer+events+(REDUCE)+trial&amp;author=G+Andriole&amp;author=D+Bostwick&amp;author=O+Brawley&amp;author=L+Gomella&amp;author=M+Marberger&amp;volume=172&amp;publication_year=2004&amp;pages=1314-1317&amp;pmid=15371831&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, Brentano S, Mathis J, Pham J, Meyer T, et al.  APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. <span><span class="ref-journal">Clin Chem. </span>2006;<span class="ref-vol">52</span>:1089–1095.</span> [<a href="/pubmed/16627561" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=APTIMA+PCA3+molecular+urine+test:+development+of+a+method+to+aid+in+the+diagnosis+of+prostate+cancer&amp;author=J+Groskopf&amp;author=SM+Aubin&amp;author=IL+Deras&amp;author=A+Blase&amp;author=S+Bodrug&amp;volume=52&amp;publication_year=2006&amp;pages=1089-1095&amp;pmid=16627561&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:906–913.</span> [<a href="/pubmed/17572673" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+new+multipoint+method+for+genome-wide+association+studies+by+imputation+of+genotypes&amp;author=J+Marchini&amp;author=B+Howie&amp;author=S+Myers&amp;author=G+McVean&amp;author=P+Donnelly&amp;volume=39&amp;publication_year=2007&amp;pages=906-913&amp;pmid=17572673&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;author=L+Thomas&amp;author=MA+Ferreira&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Lilja H, Abrahamsson PA. Three predominant proteins secreted by the human prostate gland. <span><span class="ref-journal">Prostate. </span>1988;<span class="ref-vol">12</span>:29–38.</span> [<a href="/pubmed/3347596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Three+predominant+proteins+secreted+by+the+human+prostate+gland&amp;author=H+Lilja&amp;author=PA+Abrahamsson&amp;volume=12&amp;publication_year=1988&amp;pages=29-38&amp;pmid=3347596&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic <em>in vivo</em> model of prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:2072–2078.</span> [<a href="/pubmed/12727822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Prostate+secretory+protein+PSP-94+decreases+tumor+growth+and+hypercalcemia+of+malignancy+in+a+syngenic+in+vivo+model+of+prostate+cancer&amp;author=N+Shukeir&amp;author=A+Arakelian&amp;author=S+Kadhim&amp;author=S+Garde&amp;author=SA+Rabbani&amp;volume=63&amp;publication_year=2003&amp;pages=2072-2078&amp;pmid=12727822&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Vanaja DK, Cheville JC, Iturria SJ, Young CY. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:3877–3882.</span> [<a href="/pubmed/12873976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Transcriptional+silencing+of+zinc+finger+protein+185+identified+by+expression+profiling+is+associated+with+prostate+cancer+progression&amp;author=DK+Vanaja&amp;author=JC+Cheville&amp;author=SJ+Iturria&amp;author=CY+Young&amp;volume=63&amp;publication_year=2003&amp;pages=3877-3882&amp;pmid=12873976&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S, Leongamornlert D, Tymrakiewicz M, et al.  The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e13363.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2954177/">PMC free article</a>]</span> [<a href="/pubmed/20967219" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=The+rs10993994+risk+allele+for+prostate+cancer+results+in+clinically+relevant+changes+in+microseminoprotein-beta+expression+in+tissue+and+urine&amp;author=HC+Whitaker&amp;author=Z+Kote-Jarai&amp;author=H+Ross-Adams&amp;author=AY+Warren&amp;author=J+Burge&amp;volume=5&amp;publication_year=2010&amp;pages=e13363&amp;pmid=20967219&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, et al.  Multiple newly identified loci associated with prostate cancer susceptibility. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:316–321.</span> [<a href="/pubmed/18264097" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Multiple+newly+identified+loci+associated+with+prostate+cancer+susceptibility&amp;author=RA+Eeles&amp;author=Z+Kote-Jarai&amp;author=GG+Giles&amp;author=AA+Olama&amp;author=M+Guy&amp;volume=40&amp;publication_year=2008&amp;pages=316-321&amp;pmid=18264097&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim ST, Fedor H, DeMarzo AM, Epstein JI, Walsh PC, et al.  Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. <span><span class="ref-journal">Prostate. </span>2009;<span class="ref-vol">69</span>:1195–1205.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2852875/">PMC free article</a>]</span> [<a href="/pubmed/19434657" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Individual+and+cumulative+effect+of+prostate+cancer+risk-associated+variants+on+clinicopathologic+variables+in+5,895+prostate+cancer+patients&amp;author=AK+Kader&amp;author=J+Sun&amp;author=SD+Isaacs&amp;author=KE+Wiley&amp;author=G+Yan&amp;volume=69&amp;publication_year=2009&amp;pages=1195-1205&amp;pmid=19434657&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, et al.  Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2009;<span class="ref-vol">106</span>:7933–7938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2671324/">PMC free article</a>]</span> [<a href="/pubmed/19383797" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Fine+mapping+and+functional+analysis+of+a+common+variant+in+MSMB+on+chromosome+10q11.2+associated+with+prostate+cancer+susceptibility&amp;author=H+Lou&amp;author=M+Yeager&amp;author=H+Li&amp;author=JG+Bosquet&amp;author=RB+Hayes&amp;volume=106&amp;publication_year=2009&amp;pages=7933-7938&amp;pmid=19383797&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye Y, Wang Z, Chen H, Gao X, Wang G, et al.  Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. <span><span class="ref-journal">Cancer Sci. </span>2011;<span class="ref-vol">102</span>:1916–1920.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3581323/">PMC free article</a>]</span> [<a href="/pubmed/21756274" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Systematic+confirmation+study+of+reported+prostate+cancer+risk-associated+single+nucleotide+polymorphisms+in+Chinese+men&amp;author=F+Liu&amp;author=AW+Hsing&amp;author=X+Wang&amp;author=Q+Shao&amp;author=J+Qi&amp;volume=102&amp;publication_year=2011&amp;pages=1916-1920&amp;pmid=21756274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Lu Y, Zhang Z, Yu H, Zheng SL, Isaacs WB, Xu J, Sun J. Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. <span><span class="ref-journal">Prostate. </span>2011;<span class="ref-vol">71</span>:955–963.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3070182/">PMC free article</a>]</span> [<a href="/pubmed/21541972" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Functional+annotation+of+risk+loci+identified+through+genome-wide+association+studies+for+prostate+cancer&amp;author=Y+Lu&amp;author=Z+Zhang&amp;author=H+Yu&amp;author=SL+Zheng&amp;author=WB+Isaacs&amp;volume=71&amp;publication_year=2011&amp;pages=955-963&amp;pmid=21541972&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Biancolella M, Valentini A, Minella D, Vecchione L, D'Amico F, Chillemi G, Gravina P, Bueno S, Prosperini G, Desideri A, et al.  Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. <span><span class="ref-journal">Invest New Drugs. </span>2007;<span class="ref-vol">25</span>:491–497.</span> [<a href="/pubmed/17636412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+New+Drugs&amp;title=Effects+of+dutasteride+on+the+expression+of+genes+related+to+androgen+metabolism+and+related+pathway+in+human+prostate+cancer+cell+lines&amp;author=M+Biancolella&amp;author=A+Valentini&amp;author=D+Minella&amp;author=L+Vecchione&amp;author=F+D'Amico&amp;volume=25&amp;publication_year=2007&amp;pages=491-497&amp;pmid=17636412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Williams SA, Xu Y, De Marzo AM, Isaacs JT, Denmeade SR. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer <em>ex vivo</em> models and in prostate-targeted PSA/KLK2 double transgenic mice. <span><span class="ref-journal">Prostate. </span>2010;<span class="ref-vol">70</span>:788–796.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3454520/">PMC free article</a>]</span> [<a href="/pubmed/20058238" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Prostate-specific+antigen+(PSA)+is+activated+by+KLK2+in+prostate+cancer+ex+vivo+models+and+in+prostate-targeted+PSA/KLK2+double+transgenic+mice&amp;author=SA+Williams&amp;author=Y+Xu&amp;author=AM+De+Marzo&amp;author=JT+Isaacs&amp;author=SR+Denmeade&amp;volume=70&amp;publication_year=2010&amp;pages=788-796&amp;pmid=20058238&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. <span><span class="ref-journal">Urology. </span>1997;<span class="ref-vol">49</span>:857–862.</span> [<a href="/pubmed/9187691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Urology&amp;title=Human+glandular+kallikrein+2+(hK2)+expression+in+prostatic+intraepithelial+neoplasia+and+adenocarcinoma:+a+novel+prostate+cancer+marker&amp;author=MF+Darson&amp;author=A+Pacelli&amp;author=P+Roche&amp;author=HG+Rittenhouse&amp;author=RL+Wolfert&amp;volume=49&amp;publication_year=1997&amp;pages=857-862&amp;pmid=9187691&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Lintula S, Stenman J, Bjartell A, Nordling S, Stenman UH. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue. <span><span class="ref-journal">Prostate. </span>2005;<span class="ref-vol">63</span>:324–329.</span> [<a href="/pubmed/15599939" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Relative+concentrations+of+hK2/PSA+mRNA+in+benign+and+malignant+prostatic+tissue&amp;author=S+Lintula&amp;author=J+Stenman&amp;author=A+Bjartell&amp;author=S+Nordling&amp;author=UH+Stenman&amp;volume=63&amp;publication_year=2005&amp;pages=324-329&amp;pmid=15599939&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Becker C, Piironen T, Pettersson K, Bjork T, Wojno KJ, Oesterling JE, Lilja H. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. <span><span class="ref-journal">J Urol. </span>2000;<span class="ref-vol">163</span>:311–316.</span> [<a href="/pubmed/10604382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=Discrimination+of+men+with+prostate+cancer+from+those+with+benign+disease+by+measurements+of+human+glandular+kallikrein+2+(HK2)+in+serum&amp;author=C+Becker&amp;author=T+Piironen&amp;author=K+Pettersson&amp;author=T+Bjork&amp;author=KJ+Wojno&amp;volume=163&amp;publication_year=2000&amp;pages=311-316&amp;pmid=10604382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Nam RK, Zhang WW, Trachtenberg J, Diamandis E, Toi A, Emami M, Ho M, Sweet J, Evans A, Jewett MA, et al.  Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:2312–2319.</span> [<a href="/pubmed/12805332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Single+nucleotide+polymorphism+of+the+human+kallikrein-2+gene+highly+correlates+with+serum+human+kallikrein-2+levels+and+in+combination+enhances+prostate+cancer+detection&amp;author=RK+Nam&amp;author=WW+Zhang&amp;author=J+Trachtenberg&amp;author=E+Diamandis&amp;author=A+Toi&amp;volume=21&amp;publication_year=2003&amp;pages=2312-2319&amp;pmid=12805332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Nam RK, Zhang WW, Klotz LH, Trachtenberg J, Jewett MA, Sweet J, Toi A, Teahan S, Venkateswaran V, Sugar L, et al.  Variants of the hK2 protein gene (<em>KLK2</em>) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:6452–6458.</span> [<a href="/pubmed/17085659" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Variants+of+the+hK2+protein+gene+(KLK2)+are+associated+with+serum+hK2+levels+and+predict+the+presence+of+prostate+cancer+at+biopsy&amp;author=RK+Nam&amp;author=WW+Zhang&amp;author=LH+Klotz&amp;author=J+Trachtenberg&amp;author=MA+Jewett&amp;volume=12&amp;publication_year=2006&amp;pages=6452-6458&amp;pmid=17085659&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3612916&amp;issue-id=221284&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140649776395040title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Materials and Methods</a></li><li><a href="#__sec8title">Results</a></li><li><a href="#__sec9title">Discussion</a></li><li><a href="#__sec10title">Supplementary Material</a></li><li><a href="#idm140649779518208title">Acknowledgments</a></li><li><a href="#idm140649778031904title">Abbreviations</a></li><li><a href="#idm140649779516688title">Footnotes</a></li><li><a href="#idm140649777999136title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Neoplasia (New York, N.Y.)</span> are provided here courtesy of <strong>Neoplasia Press</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3612916/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3612916/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3612916/pdf/neo1504_0448.pdf">PDF (455K)</a></li> | <li><a href="#" data-citationid="PMC3612916" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3612916%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3612916%2F&amp;text=Genome-wide%20Association%20Study%20Identifies%20Genetic%20Determinants%20of%20Urine%20PCA3%20Levels%20in%20Men" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3612916%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23555189" data-aiid="3612916" data-aid="3612916" data-iid="221284" data-domainid="367" data-domain="neoplasia" data-accid="PMC3612916" data-md5="1278a1f02a9b76e492ffc0f6f9bd598e"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:39:45-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8C66DDDD551C3100000000091305E8&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3612916%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=neoplasia&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3612916/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>